Phosphoprotein Enriched in Diabetes (PED/PEA15) Promotes Migration in Hepatocellular Carcinoma and Confers Resistance to Sorafenib

Cell Death and Disease - United Kingdom
doi 10.1038/cddis.2017.512
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

MicroRNA‑223 Promotes Hepatocellular Carcinoma Cell Resistance to Sorafenib by Targeting FBW7

Oncology Reports
MedicineCancer ResearchOncology
2018English

TGFβ Signaling Confers Sorafenib Resistance via Induction of Multiple RTKs in Hepatocellular Carcinoma Cells

Molecular Carcinogenesis
Cancer ResearchMolecular Biology
2016English

Sorafenib in Hepatocellular Carcinoma

Clinical Medicine. Therapeutics
2009English

LncRNA DANCR Promotes Sorafenib Resistance via Activation of IL-6/STAT3 Signaling in Hepatocellular Carcinoma Cells

OncoTargets and Therapy
OncologyPharmacology
2020English

The Microenvironmental and Metabolic Aspects of Sorafenib Resistance in Hepatocellular Carcinoma

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2020English

BCAT1 Promotes Tumor Cell Migration and Invasion in Hepatocellular Carcinoma

Oncology Letters
Cancer ResearchOncology
2016English

TARBP2-mediated Destabilization of Nanog Overcomes Sorafenib Resistance in Hepatocellular Carcinoma

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2019English

Cytotoxicity of Sorafenib in Human Hepatocellular Carcinoma Cells

Al-Azhar Journal of Pharmaceutical Sciences
2015English

Sorafenib vs Nivolumab in Patients With Hepatocellular Carcinoma

Journal of Liver Research, Disorders & Therapy
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy